Supplementary Materials

The PDF file includes:

  • Materials and Methods
  • Fig. S1. Peripheral eosinophil percentage and EASI score before treatment with etokimab.
  • Fig. S2. Skin blister leukocytes.
  • Fig. S3. Etokimab binding to IL-33.
  • Fig. S4. Neutrophil migration and CXCR1.
  • Table S1. Characteristics of the patients.
  • Reference (46)

[Download PDF]

Other Supplementary Material for this manuscript includes the following: